Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years

Journal of Clinical Oncology

Volumn 30, Issue 16, 2012, Pages 1926-1933

  Sauer, Rolf ^a   Liersch, Torsten ^b   Merkel, Susanne ^a   Fietkau, Rainer ^a   Hohenberger, Werner ^a   Hess, Clemens ^b   Becker, Heinz ^b   Raab, Hans Rudolf ^c   Villanueva, Marie Therese ^a   Witzigmann, Helmut ^d   Wittekind, Christian ^e   Beissbarth, Tim ^b   Rod̈el, Claus ^f  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

^d ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE PERIOD; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84860918386     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.1836     Document Type: Article

References (15)

1. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991
2. Gastrointestinal Tumor Study Group: Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 10:549-557, 1992
3. Minsky BD, Röedel C, Valentini V: Combined modality therapy for rectal cancer. Cancer J 16:253-261, 2010
4. Roh MS, Colangelo LH, O'Connell MJ, et al: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27:5124-5130, 2009
5. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
6. Pichmaier HD, Sauer R: Konsenus der CAO, AIO und ARO zur adjuvanten Therapie bei Kolonund Rektumkarzinom vom 11. März 1994 (in German). Chirurg 65:411-412, 1994
7. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
8. Peeters KC, Marijnen CA, Nagtegaal ID, et al: The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693-701, 2007 (Pubitemid 350035641)
9. van Gijn W, Marijnen CA, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575-582, 2011
10. Merkel S, Mansmann U, Hohenberger W, et al: Time to locoregional recurrence after curative resection of rectal carcinoma is prolonged after neoadjuvant treatment: A systematic review and meta-analysis. Colorectal Dis 13:123-131, 2011
11. Bosset JF, Collette L, Calais G, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006 (Pubitemid 44394918)
12. Gérard JP, Conroy T, Bonnetain F, et al: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24:4620-4625, 2006 (Pubitemid 46630960)
13. Sebag-Montefiore D, Stephens RJ, Steele R, et al: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 373:811-820, 2009
14. Rödel C, Sauer R: Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther Onkol 183:227-235, 2007 (Pubitemid 46725993)
15. Roedel C, Becker H, Fietkau R, et al: Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial. ASCO Meeting Abstracts J Clin Oncol 29:222s, 2011 (suppl: abstr LBA3505)